Benoît Rousseau

Benoît Rousseau

Auto-generated profile, based on publicly available information

Benoît Rousseau

Animalerie A2, University of Bordeaux, F-33000 Bordeaux, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FMFrancois Moisan
Francois Moisan
SOSandra OUCHERIF
Sandra OUCHERIF
PKPriscilla Kaulanjan-Checkmodine
Priscilla Kaulanjan-Checkmodine
SPSorilla Prey
Sorilla Prey
BRBenoît Rousseau
Benoît Rousseau
HRHamid-Reza REZVANI
Hamid-Reza REZVANI
Significance: Although a role for β-adrenergic receptor (ADRB) in cancer progression was suggested a long time ago, our serendipitous observation of the propranolol efficacy in treating infantile hemangioma (IH) has driven attention in exploring the antitumor properties of β-blockers. We identified Aquaporine-1 (AQP1) as a player in antitumor propranolol response and as a histological marker of IH vascular structures including telocytes, which are dendritic cells that form a distinctive peripheral layer in IH. We conclude that IH sensitivity to propranolol may rely, at least in part, on a cross talk between lesional vascular cells and stromal telocytes.